Barrett & Company’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.38K Buy
67
+7
+12% +$160 ﹤0.01% 649
2026
Q1
$1.32K Sell
60
-10
-14% -$174 ﹤0.01% 599
2025
Q4
$825 Hold
70
﹤0.01% 624
2025
Q3
$1.11K Hold
70
﹤0.01% 604
2025
Q2
$802 Hold
70
﹤0.01% 612
2025
Q1
$947 Hold
70
﹤0.01% 585
2024
Q4
$1.18K Hold
70
﹤0.01% 576
2024
Q3
$1.42K Hold
70
﹤0.01% 547
2024
Q2
$1.58K Hold
70
﹤0.01% 554
2024
Q1
$1.84K Sell
70
-20
-22% -$570 ﹤0.01% 552
2023
Q4
$2.84K Hold
90
﹤0.01% 515
2023
Q3
$2.52K Hold
90
﹤0.01% 527
2023
Q2
$3.32K Hold
90
﹤0.01% 497
2023
Q1
$2.69K Hold
90
﹤0.01% 491
2022
Q4
$2.76K Hold
90
﹤0.01% 496
2022
Q3
$2.76K Buy
+90
New +$2.97K ﹤0.01% 496

Other funds holding CC

Barrett & Company's CC Position: Q2 2026 in Review

Barrett & Company increased its Chemours (CC) stake by 12% in Q2 2026, buying an estimated $160 and bringing the position to 67 shares worth $1.38K. The position accounts for ﹤0.01% of the portfolio, ranked #649.

Barrett & Company first reported a position in CC in Q3 2022 and has held it in 16 quarters since. The position peaked at $3.32K in Q2 2023. 474 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Barrett & Company held 67 shares of Chemours worth $1.38K as of Q2 2026.
  • Barrett & Company bought 7 Chemours shares in Q2 2026, an estimated $160.
  • Chemours made up ﹤0.01% of Barrett & Company's portfolio in Q2 2026, its #649 holding.
  • Barrett & Company first reported a position in Chemours in Q3 2022 and has held it in 16 quarters since.
  • Barrett & Company's Chemours position peaked at $3.32K in Q2 2023.
  • 474 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.